알림
뒤로

PRODUCT

The Science Behind RE-CODE

Ji-Sook Moon, CEO

20+ Years as a Researcher in Alzheimer's Disease, Parkinson's Disease, and MSA

Present
RE-CODE Inc. | Founder & CEO

Leading the development of the world's first NT-SCs-based therapy for 

Multiple System Atrophy (MSA)

Present
CHA University | Professor, Department of Bioengineering 

Member, Basic Research Promotion Committee, 

National Science and Technology Advisory Council

Advisor on national regenerative biotechnology policy

  2010
CHA University | Chair, Department of Bioengineering

Director, CHA Clinical Neural Stem Cell Research Center

Inventor of the NT-SCs platform with 30+ patents

~2000
Harvard Medical School | Postdoctoral Research Fellow
Conducted postdoctoral research in neural stem cells and regenerative medicine
~2000
Cornell University | M.S., Ph.D.

Earned M.S. and Ph.D. degrees

Built expertise in neuroscience, molecular nutrition, cell biology, and biostatistics

Education & Experience


Cornell University

Ph.D. in Neuroscience & Nutrition
M.S. in Statistics


Harvard Medical School

Postdoctoral Research Fellow


CHA University 

Professor, Department of Bioengineering

Advisory & 

Review Activities 

Mar. 2021 - Dec. 2022

Advisory Committee Member, Stem Cell & Tissue Regeneration Research Division, National Research Foundation of Korea (NRF) 

Nov. 2021 - Present

Advisory Committee Member, Gangwon Medical Bio Industry Selection Evaluation Committee, Gangwon Technopark 

Apr. 2022 - Present

Senior Evaluation Committee Member, National R&D Programs, Ministry of Science and ICT (MSIT) 

Jan. 2023 - Apr. 2024

Expert Committee Member, Basic Research Division, National Research Council of Science & Technology (NST) 

RE-CODE SKIN SCIENCE

RE-CODE YOUTUBE

Regenerative Medicine 

Research in regenerative medicine provides the scientific foundation for understanding tissue repair and developing innovative therapeutic approaches. 



Aging Biology 

Aging is a biological process that affects cellular function and regenerative capacity. Understanding these mechanisms creates new possibilities for healthier aging. 



EV Platform

Extracellular vesicles (EVs) naturally transport biological signals between cells. RE-CODE develops EV technologies to advance both regenerative medicine and premium skincare.


BIOLOGICAL PRODUCTS

Advancing Innovation

Through Biological

Products

RE-CODE develops high-quality exosome products, stem cell-derived materials, and advanced skincare solution based on years of expertise in regenerative biotechnology.


In Our products are designed with a commitment to scientific rigor, quality control, and continuos innovation.